|
|
||||||||
Ann Thorac Surg 2002;73:1905-1909
© 2002 The Society of Thoracic Surgeons
a Departments of department of Anaesthesia, St Jamess Hospital, Dublin, Ireland
b Department of Hereditary Coagulation Disorders, St Jamess Hospital, Dublin, Ireland
c Department of Cardiothoracic Surgery, St. Jamess Hospital, Dublin, Ireland
Accepted for publication February 17, 2002.
* Address reprint requests to Dr Ryan, Department of Anaesthesia, St. Jamess Hospital, James St, Dublin 8, Ireland
e-mail: ryants{at}iol.ie
| Abstract |
|---|
|
|
|---|
Methods. Routine postoperative cardiac surgery patients were studied. Lactic acid levels were greater than 4 mmol/L in study patients and less than 4 mmol/L in controls. Polymerase chain reaction-based techniques were used to examine carriage of tumor necrosis factor ß (TNF-ß), TNF G-308A, and interleukin 10 (IL-10) G-1082A alleles.
Results. Demographic characteristics and details of surgery were similar for 30 control and 21 study patients. Lactic acid levels after intensive care admission changed over time and were related to both TNF-ß and IL-10 G-1082A polymorphisms. All 4 study patients homozygous for TNF-ß1 and carrying an IL-101082A allele developed lactic acidosis (p = 0.02). There was no relation between the rate of epinephrine infusion or duration of cardiopulmonary bypass and lactic acid levels.
Conclusions. Genetic factors have a role in the development of lactic acidosis after cardiac surgery.
| Introduction |
|---|
|
|
|---|
Interindividual variation in TNF production in patients with sepsis has been linked to polymorphisms in the TNF-ß gene [6]. Polymorphisms in the TNF-
promoter gene are associated with excess mortality in septic shock [7]. Interleukin 10 (IL-10) is a potent antiinflammatory cytokine that inhibits TNF production. Polymorphisms in IL-10 promoter genes are associated with variation in IL-10 production [8]. It is plausible that these cytokine genomic polymorphisms modulate cytokine production and systemic inflammation in cardiac surgical patients and that the occurrence and severity of lactic acidosis in these patients is influenced by the presence of TNF and IL-10 genetic polymorphism. We conducted a study to test this hypothesis.
| Patients and methods |
|---|
|
|
|---|
Patient demographic characteristics and history of myocardial infarction, hypertension, congestive heart failure, vascular surgery, and diabetes were collected. The nature of the surgical procedure, duration of cardiopulmonary bypass and the minimum temperature on cardiopulmonary bypass (CPB), the first and last arterial blood gases on cardiopulmonary bypass, the blood flows and hemoglobin concentrations on cardiopulmonary bypass that corresponded with these blood gases, and the least blood flow on cardiopulmonary bypass were documented.
A case-control study was performed with study patients having arterial lactic acid level in excess of 4 mmol/L at any time in the first 24 hours after cardiac surgery and a control group with lactic acid level never greater than 4 mmol/L in the first 24 hours after surgery. Lactic acid levels, hemodynamics, inotropic requirement, arterial blood gases were recorded at the end of cardiopulmonary bypass, on arrival in the intensive care, and 6, 12, and 24 hours later. The duration of postoperative mechanical ventilation and the blood loss in the first 12 hours after surgery were recorded.
Genetic analysis was performed by a person who was unaware of group allocation and lactic acid levels. DNA was extracted from whole blood using overnight proteinase K (1 mg/mL) cell lysis at 37°C in the presence of 0.5% sodium dodecyl sulfate followed by extraction with phenol/chloroform and precipitation with ethanol. Polymerase chain reaction (PCR) amplification of all polymorphic sites was performed in a 50 µL total volume. The standard reaction mix consisted of Taq DNA Polymerase buffer with MgCl2 (Promega; 50 mmol/L KCl, 10 mmol/L Tris-HCl [pH 9.0], 0.1% Triton X-100, and 1.5 mmol/L MgCl2), 0.4 U of DNA Taq polymerase, 2 µL of genomic DNA, 4% dimethyl sulfoxide (DMSO), 30 µmol/L each of deoxyribonucleoside triphosphates, and 0.2 µmol/L each of sense primer and antisense primer (Appendix 1). The cycling variables for each assay are listed in Appendix 2, along with any changes to the standard PCR reaction mix. Restriction enzymes used for each assay are listed in Appendix 2. The IL-6, TNF-
, IL-101082, and IL-10592 PCR products were digested with the appropriate enzyme overnight at 37°C. The TNF-ß PCR product was digested for 3 hours at 37°C, and the IL-1ß PCR product was digested for 12 hours at 65°C. Restriction digest products were run in the appropriate percentage of agarose gel containing 1.6 µg/mL ethidium bromide.
Continuous variables were analyzed with Students t test and analysis of variance (ANOVA). The
2 test and Fishers exact test were used to compare categorical variables. The relation between lactic acid levels and individual polymorphisms was analyzed at each time point using Students t test or ANOVA where appropriate. Where association between an individual polymorphism and lactic acid levels was detected on such a univariate test, then the interaction between polymorphism and change in lactic acid levels with time was analyzed by multivariate ANOVA (MANOVA) with repeated measures. The institutional ethics committee approved this study in March 1999.
| Results |
|---|
|
|
|---|
|
|
|
|
There was no relation between blood pressure, central venous pressure, and genotype. There was no significant relation between genotype and postoperative blood loss. There was no association between lactic acid levels 6 hours after intensive care admission and infusion rate of epinephrine (lactic acid level mmol/L = 3.5 + 11.7 epinephrine
g/kg per minute, p = 0.4).
| Comment |
|---|
|
|
|---|
Excess lactic acid accumulation after CPB has been attributed to splanchnic hypoperfusion with reperfusion in the initial hours following surgery and it is not inconceivable that visceral regional hypoperfusion might occur on a frequent basis during cardiopulmonary bypass. However, Haisjackl and colleagues [9] measuring splanchnic blood flow with indocyanine green and using gastric tonometry for mucosal pH measurement found no evidence of splanchnic hypoperfusion. Indeed post-CPB splanchnic perfusion and lactic acid levels were both increased compared with pre-CPB levels, suggesting that splanchnic lactic acid production after cardiac surgery is related to systemic inflammation. Cremer and associates [3] investigated the "low systemic vascular syndrome" after CPB and found that patients with low systemic vascular resistance had greatly increased levels of TNF and that this excess TNF was always associated with a concomitant lactic acidosis. Thus lactic acid production after CPB can be a manifestation of TNF-mediated systemic inflammation rather than hypoperfusion.
The association between inflammatory cytokines and excess lactic acid production is well recognized in sepsis related organ failure. In this setting excess production of lactic acid parallels excess inflammatory cytokine production in organs that are failing [10]. Vary and colleagues [5] in an animal model linked TNF with inhibition of pyruvate dehydrogenase and excess lactic acid production. Using a rat model of sepsis, they observed that anti-TNF antibody reversed both TNF-mediated pyruvate dehydrogenase inhibition and excess lactate production.
Epinephrine and other potent ß-adrenergic agonists may cause lactic acidosis [11]. The mechanism for this is unclear but a hypothesis suggests that coupling of membrane bound Na/K ATPases and anaerobic glycolytic enzymes may be responsible. Lactic acidosis has been reported with epinephrine administration after cardiopulmonary bypass [12]. Totaro and Raper [12] reported that 6 of 18 patients who received epinephrine after cardiopulmonary bypass developed lactic acidosis whereas none of 17 patients in a norepinephrine group had lactic acidosis. The study did not determine why only a third of patients developed acidosis in the epinephrine group. As this study did not include patients with lactic acidosis who did not require inotropic support, the occurrence of lactic acidosis in such patients was not investigated.
TNF-
and TNF-ß are similar compounds and both are active at TNF receptors [13]. TNF-
is primarily produced by activated monocytes and TNF-ß by activated lymphocytes. The B1 allele of the TNF-ß polymorphism was first associated with excess TNF-ß production by Messer and colleagues [14] and has been associated with greater severity of colitis by Koss and associategs [15]. Many polymorphisms in the TNF-
promoter gene have been described and of these, the functional significance and disease association of the TNF-G308A polymorphism is best documented. This TNF-
polymorphism is associated with enhanced gene transcription [16], a 3.75-fold increase in mortality with septic shock [7], and a sevenfold excess mortality from cerebral malaria [17]. Thus TNF-
and TNF-ß polymorphisms are functional and modulate inflammation. The TNF-B1 allele occurs with greater frequency than the TNF308A allele and as a consequence it is easier to investigate in a small study such as this. The present study was too small to determine the effects of the TNF-G308A polymorphism. IL-10 is a potent antiinflammatory cytokine that inhibits TNF production. The A allele of a polymorphism at position -1082 in the IL-10 gene promoter region is associated with lower IL-10 production [5]. In inflammatory bowel disease carriage of the IL-101082A allele is associated with greater severity of disease [15]. Thus a genotype associated with excess TNF-ß and a decrease in IL-10 could be characterized as proinflammatory. We observed that all patients with this genotype had excess lactic acid. If one considered an additional patient homozygous for TNF308A and carrying the IL-101082A alleles in this proinflammatory genotype then the association would be more prominent.
This study demonstrated that a combination of cytokine genetic polymorphisms interact to promote lactic acidosis. It is possible that patients with this proinflammatory genotype may develop systemic inflammation and lactic acidosis after a lower threshold stimulus. However only 20% of patients in the study group had the identified genotype. Thus the proinflammatory genotype identified was sufficient but not necessary to initiate systemic inflammation. Further study is required to determine whether alternate genetic factors are associated with lactic acidosis in cardiac surgical patients. It is likely that the etiology underlying the generation of systemic inflammation after cardiopulmonary bypass is multifactorial. Surgical factors such as prolonged cardiopulmonary bypass and temperature reduction during cardiopulmonary bypass likely act as a trigger to precipitate systemic inflammation. We excluded patients with prolonged, complex, or eventful surgery and thus the effects of these factors were minimized. Further study is required to determine the relative importance of genetic and surgical factors in the occurrence of lactic acidosis after cardiac surgery.
The small size of this study and a focus on low-risk patients excluded any possibility of relating genotype and outcome measures. More extensive study for an association between genotype and outcome will follow this study. Having genetic information on a patients inflammatory response before surgery may have distinct benefits. Beside the basic science interest concerning the role and interaction of the inflammatory mediators, there could be very practical clinical benefits as those patients with genetic predisposition to high cytokine release may benefit from antiinflammatory mediator strategies.
| Acknowledgments |
|---|
|
|
|---|
| Appendix 1 |
|---|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IL = interleukin; TNF = tumor necrosis factor.
| Appendix 2 |
|---|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IL = interleukin; TNF = tumor necrosis factor.
| Appendix 3 |
|---|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BSA = Body surface area in square meters; NS = not significant.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
R. Alston, C Theodosiou, and K Sanger Changing the priming solution from Ringer's to Hartmann's solution is associated with less metabolic acidosis during cardiopulmonary bypass Perfusion, November 1, 2007; 22(6): 385 - 389. [Abstract] [PDF] |
||||
![]() |
R. Ryan, J. Thornton, E. Duggan, E. McGovern, M. J. O'Dwyer, A. W. Ryan, D. Kelleher, R. McManus, and T. Ryan Gene polymorphism and requirement for vasopressor infusion after cardiac surgery. Ann. Thorac. Surg., September 1, 2006; 82(3): 895 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Riha, J. A. Hubacek, R. Poledne, P. Kellovsky, A. Brezina, and J. Pirk IL-10 and TNF-beta gene polymorphisms have no major influence on lactate levels after cardiac surgery. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 54 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
R P. Alston, L. Cormack, and C. Collinson Metabolic acidosis developing during cardiopulmonary bypass is related to a decrease in strong ion difference Perfusion, May 1, 2004; 19(3): 145 - 152. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |